Skip to main content
All lobbying filings

ILLUMINA, INC.

Lobbying for ILLUMINA, INC.

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Expenses
$240,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
California

Official filing document

 Government bodies contacted 8

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 4

Discussions related to biotechnology innovations

Discussions related to U.S. government disease surveillance programs

H.R. 7118: Genomic Answers for Childrens Health Act of 2026; all provisions

General issues related to trade

 Bills named in this filing 1
  • H.R. 7118
    Genomic Answers for Children’s Health Act of 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem